This compound is primarily explored for its potential therapeutic applications, particularly as an inhibitor of histone deacetylase (HDAC) enzymes. HDAC inhibitors are widely studied for their role in cancer treatment, as they can induce cell cycle arrest, apoptosis, and differentiation in cancer cells. By modulating gene expression, this compound may help in reactivating tumor suppressor genes and inhibiting the growth of malignant cells. Additionally, it is being investigated for its potential use in treating neurodegenerative diseases, where HDAC inhibition has shown promise in enhancing cognitive function and reducing neuronal damage. Its unique structure, incorporating a biphenyl group, may also contribute to its selectivity and efficacy in targeting specific HDAC isoforms, making it a valuable candidate for further drug development.